Except for historical information contained herein, this news release
contains forward-looking statements specifically including the expected
market launch and physician acceptance of the Endologix IntuiTrak
Delivery System, the accuracy of which are necessarily subject to risks
and uncertainties, all of which are difficult or impossible to predict
accurately and many of which are beyond the control of Endologix. Read the rest of this entry »
STATEN ISLAND, N.Y. — Staten Island is in the grip of a
health insurance crisis, with an estimated 50,000 people
lacking coverage, making it the fastest growing population
among uninsured in the city, a group of local service
providers and community leaders said yesterday.
Countless more Islanders are trying to make do with limited
access to affordable medical care.
In response to their plight, the Staten Island Family
Health Coalition, in conjunction Read the rest of this entry »
It’s hard to imagine Academy Award-winning actress Geena Davis as a shy, self-conscious child.
“I felt very self-conscious all the time,” Davis told the roughly 500 women who attended Virtua’s fourth annual Women’s Health Symposium, where she was the keynote speaker. “I was convinced that I was really awkward. I didn’t want to play sports because I didn’t want anybody to watch me do anything.”
During a candid interview with Philadelphia Magazine Read the rest of this entry »
(Adds details and background throughout; comments from J&J CEO beginning in
5th paragraph; updates stock price.)
(JNJ) reported a 14% increase in fourth-quarter profit, as
cost cuts and one-time gains helped offset declines in sales of its
pharmaceuticals and medical devices, as well as a marked slowdown in consumer
products sales.
New Brunswick, N.J.
, health-care giant, which makes the pain reliever
Tylenol, also issued a forecast of 2009 Read the rest of this entry »
DURHAM, N.C., Jan. 6 — In obese patients with type 2 diabetes, the ketogenic diet — which stresses high fat and low carbohydrate intake — outperformed its low-glycemic index rival, researchers found.
After six months, improvements in blood glucose control, as measured by hemoglobin A1c, were significantly greater with the ketogenic diet based on the
than with a low-glycemic index, reduced-calorie diet, (–1.5% versus –0.5%,
=0.03), Eric Read the rest of this entry »
ScienceDaily (Feb. 11, 2009)
— A new study shows that computerized brain exercises can improve memory and lead to faster thinking.
Prior studies have shown that older adults perform better on cognitive tests after repeatedly practicing those tests, but this large-scale study is the first to link a commercially available software program to improvement on unaffiliated standard measures of memory and to better performance on everyday tasks. Read the rest of this entry »
SKANEATELES FALLS, N.Y., Nov 24, 2008 (BUSINESS WIRE) –
Welch Allyn, a leading global manufacturer of frontline medical products
and solutions, utilizes next generation wireless infrastructure in
FlexNet(TM), a new HIPAA-compliant, real-time continuous patient monitoring
solution for acute care settings. The new solution utilizes Welch
Allyn’s exclusive 802.11a wireless radio technology in patient-related Read the rest of this entry »
November 24, 2008 12:36 am
By Robert Barron, Staff Writer
Enid could have its own veteran’s clinic by June 2009, according to officials working with the Oklahoma City VA Medical Center.
Craig Vance, an Enid veteran who has been working with the veterans hospital in Oklahoma City, said the facility will be contractor-operated rather than through Veterans Affairs.
They are reportedly working to have the facility open by June 1, 2009. Read the rest of this entry »
FRIDAY, Dec. 12 (HealthDay News) — Information patients commonly receive about the risk of their breast cancer returning after surgery may make their decision on whether to get chemotherapy more difficult, a new study concludes.
Doctors typically show breast cancer patients a bar chart, based on a standard risk-assessment tool, with four different post-surgery choices: hormonal therapy alone, chemotherapy alone, hormonal therapy and chemotherapy Read the rest of this entry »
(RTTNews) -
Syneron Medical Ltd. (ELOS:
) is showing weakness during pre-market trading on Thursday following the release of quarterly results. At 9:24 am ET the stock is trading at $6.25 down $1.06 from Wednesday’s close.
With the decline, the stock is indicated to open at its lowest level in over two months.
The company reported fourth quarter net loss of $15.87 million, or $0.58 per share, compared Read the rest of this entry »